Spruce Biosciences, Inc.
SPRB
$0.0856
-$0.0442-34.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.77% | -44.41% | -42.18% | -31.56% | 21.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.03% | -1.08% | -20.65% | -8.77% | 16.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.65% | 105.25% | 643.20% | 536.76% | 62.51% |
| Total Current Assets | -56.74% | -42.80% | -40.46% | -37.43% | 22.22% |
|
|
|||||
| Total Current Assets | -56.74% | -42.80% | -40.46% | -37.43% | 22.22% |
| Net Property, Plant & Equipment | -20.91% | -19.52% | -18.27% | -17.15% | -15.64% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -88.14% | -12.52% | 2.05% | 5.33% | -9.06% |
| Total Assets | -56.51% | -42.38% | -40.05% | -37.07% | 21.36% |
|
|
|||||
| Total Accounts Payable | -61.13% | -42.93% | -27.83% | -45.16% | 133.66% |
| Total Accrued Expenses | -16.05% | -34.36% | -12.26% | 37.96% | 54.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71% | 1.66% | 1.67% | 1.62% | 6.36% |
| Total Finance Division Other Current Liabilities | -- | -91.06% | -83.90% | -68.41% | -- |
| Total Other Current Liabilities | -- | -91.06% | -83.90% | -68.41% | -- |
| Total Current Liabilities | -37.68% | -50.98% | -37.16% | -20.01% | 96.55% |
|
|
|||||
| Total Current Liabilities | -37.68% | -50.98% | -37.16% | -20.01% | 96.55% |
| Long-Term Debt | -92.78% | -75.20% | -63.18% | -54.46% | -47.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -27.77% | -25.30% | -23.28% | -21.42% | -19.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.49% | 24.09% | -91.30% | -93.77% | 46.58% |
| Total Liabilities | -40.27% | -51.22% | -44.39% | -32.79% | 59.87% |
|
|
|||||
| Common Stock & APIC | 1.95% | 2.08% | 2.09% | 1.92% | 25.36% |
| Retained Earnings | -26.89% | -21.05% | -24.64% | -28.84% | -32.09% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -62.33% | -39.52% | -38.72% | -38.31% | 11.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -62.33% | -39.52% | -38.72% | -38.31% | 11.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -62.33% | -39.52% | -38.72% | -38.31% | 11.71% |
|
|
|||||